DEFERASIROX
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
62332-412 -
Package NDC
62332-412-30 -
Package NDC
62332-412-91 -
Application number
ANDA211824 -
SPL ID
6d1323aa-ee46-43aa-bcf0-d83a36788a1c -
SPL set ID
f1f952c8-89f5-4a2f-bd6b-9b384366d971 -
UNII
V8G4MOF2V9 -
RxCUI
1607784 -
RxCUI
1607792 -
RxCUI
1607796
What the source publishes
- Labeler
- Alembic Pharmaceuticals Inc.
- Active ingredients
- DEFERASIROX
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "DEFERASIROX",
"splId": "6d1323aa-ee46-43aa-bcf0-d83a36788a1c",
"labels": [
{
"setId": "f1f952c8-89f5-4a2f-bd6b-9b384366d971",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1f952c8-89f5-4a2f-bd6b-9b384366d971",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f1f952c8-89f5-4a2f-bd6b-9b384366d971"
}
],
"routes": [
"ORAL"
],
"labeler": "Alembic Pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, FILM COATED in 1 BOTTLE (62332-412-30)",
"package_ndc": "62332-412-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20191121"
},
{
"sample": false,
"description": "1000 TABLET, FILM COATED in 1 BOTTLE (62332-412-91)",
"package_ndc": "62332-412-91",
"identifierStatus": "well-formed",
"marketing_start_date": "20191121"
}
],
"productId": "62332-412_6d1323aa-ee46-43aa-bcf0-d83a36788a1c",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "62332-412",
"deaSchedule": null,
"genericName": "DEFERASIROX",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DEFERASIROX",
"strength": "360 mg/1"
}
],
"applicationNumber": "ANDA211824",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20191121",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000144",
"N0000175522",
"N0000185506",
"N0000187062",
"N0000182138"
],
"upc": [
"0362332411306",
"0362332410309"
],
"unii": [
"V8G4MOF2V9"
],
"rxcui": [
"1607784",
"1607792",
"1607796"
],
"spl_set_id": [
"f1f952c8-89f5-4a2f-bd6b-9b384366d971"
],
"pharm_class_epc": [
"Iron Chelator [EPC]"
],
"pharm_class_moa": [
"Iron Chelating Activity [MoA]",
"Cytochrome P450 3A4 Inducers [MoA]",
"Cytochrome P450 2C8 Inhibitors [MoA]",
"Cytochrome P450 1A2 Inhibitors [MoA]"
],
"manufacturer_name": [
"Alembic Pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:62332-412_6d1323aa-ee46-43aa-bcf0-d83a36788a1c"